Expanded Glucose Import Capability Affords Staphylococcus aureus Optimized Glycolytic Flux during Infection

ABSTRACT Acquisition of numerous virulence determinants affords Staphylococcus aureus greater pathogenicity than other skin-colonizing staphylococci in humans. Additionally, the metabolic adaptation of S. aureus to nonrespiratory conditions encountered during infection (e.g., hypoxia, nitric oxide, iron chelation) has been implicated as contributing to S. aureus virulence. Specifically, S. aureus has been shown to ferment glycolytic substrates in nonrespiratory environments encountered within the host. Here, we show that S. aureus has acquired unique carbohydrate transporters that facilitate the maximal uptake of host sugars and serve to support nonrespiratory growth in inflamed tissue. The carbohydrate substrates of 11 S. aureus transporters were identified, and at least four of their genes encode S. aureus glucose transporters (glcA, glcB, glcC, and glcU). Moreover, two transporter genes (glcA and glcC) are unique to S. aureus and contribute disproportionately to the nonrespiratory growth of S. aureus on glucose. Targeted inactivation of sugar transporters reduced glucose uptake and attenuated S. aureus in a murine model of skin and soft tissue infections. These data expand the evidence for metabolic adaptation of S. aureus to invasive infection and demonstrate the specific requirement for the fermentation of glucose over all other available carbohydrates. Ultimately, acquisition of foreign genes allows S. aureus to adopt a metabolic strategy resembling that of infiltrating host immune cells: high glycolytic flux coupled to lactate excretion.

Recently, we demonstrated that S. aureus requires both glycolysis and lactate fermentation for SSTIs and bloodstream infections and that only carbohydrates support the growth of S. aureus under both high NO stress and anaerobiosis (i.e., nonrespiratory conditions) (13,16). Additionally, the lack of abundant iron during infection limits respiration and necessitates high glycolytic flux coupled to lactate excretion (15,17). This metabolic strategy, which is similar to that of activated immune cells, allows for the generation of ATP in a redox-balanced, respirationindependent manner. However, aside from the presence of a unique lactate dehydrogenase gene (ldh1) in the S. aureus genome that promotes enhanced redox balancing during respiration inhibition, there is a lack of molecular evidence supporting a contribution of metabolic adaptation to infection as a distinguishing characteristic of S. aureus (13). Given the high evolutionary conservation of glycolysis among the kingdoms of life, we postulated that metabolic adaptation to promote high glycolytic flux would most easily be achieved by the acquisition of additional carbohydrate importers (18).
Bacterial carbohydrate transporters can be divided into those that modify the sugar during transport (i.e., phosphotransferase system [PTS] transporters) and those that do not (i.e., primary and secondary active transporters) (19)(20)(21). PTS transport proceeds via a phosphorelay system that transfers the phosphoryl group of phosphoenolpyruvate (PEP) through a series of carrier proteins (EI and HPr) to a transporter (EII) and then on to the sugar as it is imported. PTS sugar transporters are composed of at least three subunits: EIIA, EIIB, and EIIC. The EIIA and EIIB subunits transfer the phosphoryl group from HPr to the sugar, while the EIIC subunit acts as a sugar-specific transmembrane receptor. Interestingly, the EII subunits may be encoded as individual polypeptides or fused into multisubunit proteins. PTSdependent carbohydrate transport is unique to bacteria and is the predominant form of sugar uptake. PTS-dependent transport is also functionally linked to the transcriptional regulation of cellular metabolism via carbon catabolite repression (mediated by CcpA in Gram-positive bacteria), which further contributes to overall metabolic efficiency.
In this report, we show that S. aureus exhibits better nonrespiratory growth than other skin-dwelling staphylococci and partially attribute this phenomenon to an increased capacity for carbohydrate import. More specifically, we identify the carbohydrate substrates for 11 putative sugar transporters and demonstrate that S. aureus exhibits preferential uptake of glucose during infection as a result of the combined activities of at least four glucose transporters, two of which are newly acquired and therefore unique to S. aureus.

RESULTS
S. aureus exhibits better anaerobic growth than other staphylococci. S. aureus grows in the presence of NO levels that inhibit both respiration and the growth of other staphylococci (13). To test whether this enhanced growth behavior occurs under other nonrespiratory conditions, we compared the anaerobic growth of S. aureus strains COL and LAC to that of S. epidermidis RP62A, S. haemolyticus ATCC 29970, and S. saprophyticus ATCC 15305 in a rich medium. Both strains of S. aureus exhibited better growth than the other Staphylococcus species, as evidenced by significantly greater growth rates and terminal optical densities (ODs) (Fig. 1A and B). Next, we compared the anaerobic growth of S. aureus COL to that of the other staphylococcal species in chemically defined medium (CDM) with glucose as the primary carbon source. Once again, S. aureus exhibited better anaerobic growth than the other Staphylococcus species (Fig. 1C and D). These data suggest that unique glycolytic and/or fermentative capabilities account for the enhanced growth of S. aureus under nonrespiratory conditions. S. aureus encodes an expanded repertoire of predicted carbohydrate transporters. One explanation for the increased growth rate of S. aureus under nonrespiratory conditions could be an increased capacity to import fermentable carbohydrates. To test this hypothesis, we performed a comparative genome analysis of putative carbohydrate transporters encoded by S. aureus COL, S. aureus LAC, S. epidermidis RP62A, S. haemolyticus JCSC1435, and S. saprophyticus ATCC 15305. We found that S. aureus encodes the largest total number of carbohydrate transporters (22), as well as the most unique carbohydrate transporters (10) (Fig. 2; see Table S1 in the supplemental material). Interestingly, 4 of the 10 unique S. aureus alleles are predicted to encode glucose transporters: SAUSA300_0191 (glcA), SAUSA300_0194, SAUSA300_ 0236 (glcC), and SAUSA300_0259 (see Table S1). Importantly, glucose is (i) largely absent from the skin surface, (ii) the most abundant free carbohydrate in human serum, and (iii) used by activated innate immune cells to both produce and resist inflammatory radicals.
Carbohydrate uptake in S. aureus is mostly PTS dependent and contributes disproportionately to nonrespiratory growth. The majority (21/29) of putative S. aureus carbohydrate transport proteins are predicted to be PTS proteins. Thus, we decided to test the contribution of PTS-dependent carbohydrate transport to the nonrespiratory growth of S. aureus by using a PTS-deficient stain of S. aureus (ptsH-H15A). The H15A substitution in PtsH prevents the transfer of the phosphoryl group from EI to PtsH, thereby inhibiting PTS-dependent sugar uptake but not directly affecting interactions with CcpA, the master regulator of carbon catabolite repression (21). To confirm the efficacy of this mutation and identify PTS-dependent substrates, we compared the aerobic growth of wild-type (WT) and ptsH-H15A mutant S. aureus on 16 different carbohydrates. Previous studies demonstrated PTS-dependent utilization of at least seven carbohydrates (lactose, fructose, galactose, maltose, sucrose, glucose, and mannitol) by S. aureus (23). In line with these observations, we found that loss of PTS-dependent sugar uptake prevented S. aureus growth on 10 carbohydrates (mannose, fructose, galactose, mannitol, N-acetylglucosamine, N-acetylmannosamine, maltose, sucrose, trehalose, lactose, and turanose) and reduced its growth on two carbohydrates (glucose and maltotriose) but did not affect its growth on ribose (Table 1). These data show that S. aureus carbohydrate utilization is largely PTS dependent.
Nonrespiratory fermentation of carbohydrates is inherently less energy efficient than respiration. Consequently, S. aureus must consume three times the amount of glucose under fermentative growth as under respiratory conditions in order to produce equivalent biomass (dry weight) (Fig. 3A). Maintaining this elevated level of sugar catabolism necessitates more efficient uptake of carbohydrates, particularly under nonrespiratory conditions. Accordingly, despite the large reduction in carbohydrate utilization in the PTS-deficient strain, aerobic growth of S. aureus LAC in complex medium is largely unaffected (Fig. 3B). In contrast, the PTS-deficient mutant exhibited a significant reduction in growth under anaerobic conditions (Fig. 3C), under NO stress (Fig. 3D), Vitko et al. and under metal-limited conditions (Fig. 3E). Similar results were obtained with S. aureus COL (data not shown). Thus, the increased reliance of S. aureus on carbohydrate transport during nonrespiratory growth implicates carbohydrate transporter ac-quisition as a possible mechanism of metabolic adaption of S. aureus to infection.
Substrate identification for individual S. aureus PTS proteins. To identify the sugar specificity of individual S. aureus PTS  proteins, we screened mutants with insertions in all of the predicted PTS protein-encoding genes for aerobic growth defects on selected carbohydrates. Previous studies identified fruA and mtlFA as encoding fructose and mannitol importers, respectively (24,25). In support of these observations, we found that the mtlF and mtlA mutants were unable to grow on mannitol, while S. aureus COL, a natural fruA mutant, exhibited poorer growth than S. aureus JE2 on fructose. Additionally, we identified PTS transport proteins contributing to the uptake of nine other carbohydrates. Overall, our results link individual PTS transport proteins to the uptake of 11 of the 12 PTS-dependent sugars ( Table 2). All phenotypes were confirmed in a second S. aureus strain (COL) background following transduction (data not shown). Consistent with the growth phenotypes of the ptsH-deficient mutant, not a single S. aureus PTS transposon mutant displayed a growth defect on glucose, suggesting that glucose uptake (i) is genetically redundant and (ii) likely requires both PTS and non-PTS-dependent transporters.
S. aureus glucose transport is highly redundant. To identify the S. aureus glucose transporters, four different candidate genes were mutated via allelic replacement (three PTS transporters [glcA, glcB, and SAUSA300_0236] and one non-PTS transporter [glcU]) and then combined into all possible double, triple, and quadruple mutants. The deleted genes were chosen on the basis of a combination of sequence similarity to known glucose transporters and high expression levels during aerobic growth on glucose (data not shown). We found that only the S. aureus quadruple mutant (⌬glcA ⌬glcB ⌬glcU ⌬SAUSA300_0236) exhibited a substantial aerobic growth defect on glucose (the quadruple mutant is referred to here as S. aureus ⌬G4, and the SAUSA300_0236 gene is referred to as glcC) (Fig. 4A). Additionally, each putative glucose transporter was able to independently complement the aerobic growth defect of the S. aureus ⌬G4 mutant on glucose (Fig. 4B). Lastly, we found that attenuation of ⌬G4 mutant growth was fairly specific to glucose (see Table S2 in the supplemental material) (ManNAc and GlcNAc were not tested, as GlcA and GlcC were previously implicated in their transport; see Table S1 in the supplemental material).
To confirm that glcA, glcB, glcC, and glcU encode glucose transporters, we performed radiolabeled-glucose uptake assays with WT S. aureus, the ⌬G4 mutant, and the ⌬G4 mutant containing plasmids constitutively expressing each of the four glucose transporters. The ⌬G4 mutant exhibited significantly less glucose uptake than WT S. aureus (45% of the WT level) (Fig. 4C). Complementation of the ⌬G4 mutant with glcA, glcB, glcC, or glcU increased its glucose uptake to 98, 110, 105, or 56% of the WT level, respectively. The lack of significant uptake complementation by glcU could be explained by the fact that glcU encodes a member of the glucose/ribose porter family, a family of secondary active transporters that rely on proton motive force (PMF) for energy (26,27). The dense cell pellet conditions required to perform these uptake assays likely have a negative impact on PMF. This would specifically decrease the activity of PMF-dependent GlcU more than that of the PEP-dependent PTS transporters GlcA, GlcB, and GlcC. Importantly, the S. aureus ⌬G4 mutant is still capable of importing glucose and exhibits residual aerobic growth on glucose. These data indicate the presence of an additional glucose transporter(s).
To rule out the contribution of other PTS-dependent transporters to S. aureus glucose uptake, we compared the aerobic growth of WT and ⌬G4, ptsH-H15A ⌬glcU, and ptsH-H15A ⌬glk mutant S. aureus COL. Glucose kinase, encoded by glk, is responsible for phosphorylating intracellular glucose taken up by non-PTS transporters. Thus, without glk, intracellular glucose cannot be catabolized unless transported via PTS proteins. The growth of the S. aureus ⌬G4 and ptsH-H15A ⌬glcU mutants was indistinguishable, whereas the S. aureus ptsH-H15A ⌬glk mutant exhibited no residual growth in CDM with glucose as the primary carbon source (see Fig. S1 in the supplemental material). These data indicate that one or several unidentified non-PTS-dependent transporters are responsible for the remaining S. aureus ⌬G4 glucose uptake observed.
GlcA and GlcC contribute disproportionately to the nonrespiratory growth of S. aureus on glucose. Next, we compared the aerobic, anaerobic, and NO-exposed growth of the various S. aureus glucose transporter mutants in CDM with glucose as the primary carbon source. The two triple mutants lacking both unique glucose transporters (GlcA and GlcC), and thus only expressing GlcB or GlcU, grew significantly more poorly than the other triple mutants, in which either GlcA or GlcC remained functional ( Fig. 4D and E). This suggests that the unique glucose transporters GlcA and GlcC contribute disproportionately to S. aureus growth on glucose under nonrespiratory conditions. The ability of either GlcA or GlcC alone to individually maintain WT growth under nonrespiratory conditions cannot be explained by its expression level. The glcA transcript levels were commensurate with those of glcB and glcU (see Fig. S2 in the supplemental material). Moreover, glcC transcription was less robust under all of the conditions tested. Furthermore, none of the glucose transporter genes responded to the presence or absence of glucose or to respiratory inhibition, with the exception of glcC, which showed modest induction under anaerobiosis. Thus, other factors must explain the ability of GlcA or GlcC to fully restore growth by itself, such as translation efficiency, protein stability, and/or affinity for glucose. Rich medium provides alternative carbohydrates to support nonrespiratory growth of S. aureus. We hypothesized that the acquisition of additional glucose transporters might partially explain the enhanced nonrespiratory growth phenotypes exhibited by S. aureus in both CDM and rich medium. Thus, we compared the growth of WT S. aureus (normal transport) with that of the ⌬G4 (significantly reduced glucose uptake) and ptsH-H15A ⌬glcU (severe defect in all carbohydrate import) S. aureus (COL and LAC) mutants in Bacto tryptic soy broth (TSB; BD; catalog no. 211825) under respiratory and nonrespiratory conditions. We observed almost no growth defect in the S. aureus ⌬G4 mutants under aerobic or nonrespiratory conditions in TSB (including NO stress, anaerobiosis, and metal chelation) (see Fig. S3 in the supplemental material). This suggests that glucose transport is nonessential for growth under nutrient-rich conditions, perhaps because of the presence or uptake of other carbohydrates. In line with this hypothesis, we observed an additive effect of the ⌬glcU and ptsH-H15A mutations under aerobic conditions (see Fig. S3). However, the ptsH-H15A ⌬glcU mutant exhibited drastic growth rate reductions under nonrespiratory conditions, including anaerobiosis, NO·exposure, and metal chelation (see Fig. S3). These data indicate that carbon is not a limiting factor for S. aureus in TSB and that uptake of other carbohydrates can compensate for a reduction in S. aureus glucose uptake even when high glycolytic flux is required upon respiration inhibition.
Glucose uptake contributes to S. aureus virulence in a murine SSTI model. To investigate the relative contributions of glucose and other carbohydrates to S. aureus growth or survival during infection, C57BL/6 mice were subcutaneously infected with 1 ϫ 10 7 CFU of WT or ⌬G4, ptsH-H15A, ptsH-H15A ⌬glcU, or ⌬glcU mutant S. aureus LAC. At 5 days postinfection, the S. aureus ⌬G4 mutant was significantly attenuated by the abscess burden (~1 log), while the ptsH-H15A mutant, despite losing the functions of three of the four glucose transporters and all other PTS carbohydrate transporters, was not significantly attenuated (Fig. 5A). Combining the ⌬glcU and ptsH-H15A mutations resulted in greater attenuation than S. aureus ⌬G4 alone (~2-log difference from the WT). This difference was not just due to mutation of the glcU allele, as the ⌬glcU single mutant was also not significantly attenuated in comparison with the WT. Importantly, we observed no reversion of the ptsH-H15A mutation over the course of infection.
Interestingly, when we infected mice with a dose (1 ϫ 10 8 CFU) that results in measurable skin lesions, the S. aureus ⌬G4 mutant produced almost no abscess formation, unlike the WT (Fig. 5B). However, when grown on blood agar plates, the S. aureus ⌬G4 mutant exhibited no obvious hemolysis defects (see Fig. S4 in the supplemental material). Altogether, these data suggest that glucose is the primary carbohydrate utilized by S. aureus during skin infections and that other carbohydrates contribute minimally to the growth or survival of S. aureus. This conclusion is supported by our observation that the elimination of all PTS carbohydrate transport only attenuates S. aureus when glucose transport is also limited (Fig. 5A). Factors that necessitate the fermentation of glucose during infection include iron chelation and NO production (13,15,16). Additionally, as the abscess progresses, oxygen becomes scarce, further limiting the efficiency of respiration. This becomes apparent with Hypoxyprobe staining as early as day 7 but is overwhelmingly measurable by day 12 (Fig. 5C). Thus, the combination of iron chelation, NO production, and hypoxia within S. aureus skin abscesses necessitates fermentative metabolism and the robust import of glucose by the bacterium.

DISCUSSION
Many variables within host tissue necessitate nonrespiratory growth, including the production of immune radicals, the seques-tration of iron, and the inevitable hypoxia that arises at sites of inflammation because of the rapid consumption of oxygen by active immune cells. S. aureus has evolved to thrive under all of these stresses provided it has a rich source of carbohydrates, particularly glucose. Under aerobic conditions, respiration contributes directly to PMF, which in turn is used to generate ATP. In the absence of respiration, the only source of ATP is substrate level phosphorylation. Moreover, PMF has to be adequately maintained by consumption of ATP and reversal of the F 1 F 0 -ATPase. Therefore, under nonrespiratory conditions, S. aureus requires enhanced glycolytic flux, as demonstrated by a Ͼ3-fold increase in glucose consumption (Fig. 3A).
In order to accommodate an elevated level of glycolytic flux, S. aureus must efficiently acquire host carbohydrates. Importantly, glucose is the most abundant free carbohydrate in the human body, and elevated host glucose levels are associated with greater S. aureus disease (11,22,(28)(29)(30). However, efficient glucose uptake is likely difficult in inflamed tissue spaces, given that infiltrating phagocytes rapidly consume tissue glucose by running a metabolic scheme not unlike Warburg metabolism (i.e., robust glucose oxidation combined with extensive lactate secretion) (31). Infiltrating neutrophils rely very little on the trichloroacetic acid (TCA) cycle or mitochondrial respiration, likely because these energy-efficient pathways are susceptible to the reactive immune radicals produced by these immune cells. By acquiring additional glucose uptake capabilities, as well as a highly active lactate dehydrogenase, S. aureus has distinguished itself from other skindwelling staphylococci and evolved to "mimic" the metabolic state of the host at sites of inflammation.
It should be noted that glucose is not the only substrate for the S. aureus-specific GlcA and GlcC transporters. We found that GlcA and GlcC are solely responsible for the uptake of GlcNAc and ManNAc, respectively, which may be indicative of a role in peptidoglycan homeostasis. However, the selective pressure for these transporters during infection is likely their affinity for glucose. This conclusion is drawn from the fact that the ⌬glcA ⌬glcC mutant, which is completely devoid of GlcNAc or ManNAc import, is fully virulent (data not shown). Thus, a role in cell wall homeostasis cannot explain the maintenance of these two genes. Rather, attenuation in the animal model of skin infection requires loss of either all carbohydrate transport (ptsH-H15A ⌬glcU) or specific loss of glucose transport (⌬G4) (Fig. 5A). The fact that the ptsH-H15A mutant alone (unable to utilize almost all carbohydrates, with the exception of glucose) is fully virulent implies that all other carbohydrates found within the host environment are incapable of sustaining S. aureus in vivo. In addition to meeting the energy needs of the cell, the effect of glucose on S. aureus virulence factor regulation in the context of infection should not be ignored. Specifically, in vitro glucose induces the expression of S. aureus biofilm-related genes (cidA and icaA) and modulates the expression of the genes for a master virulence regulator (agr/RNAIII), toxins (hla, sec, and tst), and protein A (spa) (32)(33)(34)(35)(36). This may explain the complete loss of lesion formation in mice infected with the ⌬G4 mutant despite only a modest reduction in the viable CFU count (Fig. 5). Although we did not observe a loss of hemolytic activity in S. aureus ⌬G4 grown in vitro on blood agar plates (see Fig. S4 in the supplemental material), this experiment is not quantitative and does not rule out a difference in the kinetics or cumulative levels of toxin production. Similarly, we found that the S. aureus ptsH-H15A ⌬glcU mutant exhibited normal hemolysis but displayed reduced pigment formation. This defect may be explained as follows: (i) slow growth of C]glucose uptake by S. aureus COL ⌬G4 relative to that of the WT, as well as ⌬G4 complemented with each individual glucose transporter gene. Uptake by each strain was measured following 12 min of incubation with radiolabeled substrate and then normalized to that of the WT (n ϭ 4; error bars show the standard error of the mean). Statistical significance was calculated with a Student two-sided t test (*, P Յ 0.05; **, P Յ 0.01; ***, P Յ 0.001). (D and E) Nonrespiratory growth rate of S. aureus COL ⌬G4, relative to that of the WT, compared to that of mutants expressing individual transporter genes from their native promoters. Strains were cultured anaerobically (D) or under NO stress (10 mM NOC-12-1 mM DEA-NO) (E) (n ϭ 3; error bars show the pooled standard error of the mean). Statistical significance was calculated with a Student two-sided t test (**, P Յ 0.01; ***, P Յ 0.001). Abs, absorbance. the mutant in TSB may delay sigB activation of the crtOPQMN operon, and/or (ii) reduced carbohydrate uptake may limit the intracellular availability of glucose, a required substrate for staphyloxanthin production (37,38). Regardless, our data indicate that carbohydrate uptake may also contribute to S. aureus infection via regulation of virulence factor production.
To contextualize our in vivo findings, one must also consider that respiration, iron acquisition, and the TCA cycle have all been shown to contribute to S. aureus virulence (39)(40)(41)(42). Thus, we cannot accurately state that inflamed tissue spaces are strictly nonrespiratory. However, it is clear from our work that S. aureus displays enhanced nonrespiratory growth phenotypes and that glycolysis-based fermentation is equally required for infection. These seemingly paradoxical findings can be reconciled by considering the temporal and spatial aspects of infection. For instance, NO production and oxygen availability are temporally regulated during S. aureus abscess development (14). Skin abscess-inducible NO synthase activity is highest 1 to 7 days after S. aureus injection and then wanes as the infection clears. However, over time, the abscesses become hypoxic (Fig. 5C). These data suggest that S. aureus uses carbohydrate-based fermentative metabolism to overcome instances of high NO exposure encountered early during infection and instances of hypoxia later in infection. Moreover, bacteria within murine renal abscess have been shown to be relatively starved of iron (43). Thus, until bacterial numbers are reached such that efficient hemolysis releases hemoglobin into the tissue, allowing S. aureus sufficient iron to respire, S. aureus may rely on nonrespiratory metabolism to thrive, necessitating rapid import of glucose.
Regardless of when or why S. aureus glycolytic and glucose transporter-deficient mutants are attenuated during infection, the fact that they exhibit any attenuation at all emphasizes the importance of glucose to S. aureus disease. In particular, this observation may partially explain the unique susceptibility of uncontrolled diabetics to S. aureus infections (30). Diabetes is an important risk factor for S. aureus disease, with diabetic individuals exhibiting an increased incidence and severity of S. aureus SSTIs, bloodstream infections, and endocarditis (22,28,29,(44)(45)(46). If the susceptibility of diabetics to S. aureus infection is, in fact, augmented by the enhanced propensity of S. aureus to acquire and ferment glucose, then the development of novel S. aureus glycolysis inhibitors by Kumar et al. may constitute a particularly effective treatment for diabetics with S. aureus infections, one that both limits S. aureus growth and reduces its destructive capacity during infection (47).

MATERIALS AND METHODS
Bacterial strains and medium. All staphylococci were cultivated in TSB or CDM, wherein the primary carbon source could be modified (48). Individual carbohydrates added to CDM were carbon balanced to 25 mM glucose for all experiments, except the NO growth assay (see explanation below). Casamino Acids were added to the CDM at 0.5%. Chloramphenicol was added to TSB (10 g/ml) and CDM (2.5 g/ml) during the growth of plasmid-containing strains. All of the strains utilized in this study are listed in Table S3 in the supplemental material. All mutant strains, except the PTS insertion mutants, were generated via allelic replacement with Escherichia coli-S. aureus shuttle vectors pBT2ts, pBTK, pBTE, and pBTS and the new vector pBTT as previously described (49). pBTT was constructed by amplifying the tetK allele from S. aureus COL plasmid pT181 (tet.3A and tet.3B) and then cloning it into the XmaI site of pBT2ts. The PTS insertion mutants were ordered from the Nebraska Mutant Transposon Library (Network on Antimicrobial Resistance in Staphylococcus aureus) and verified by PCR upon arrival (24). For the plasmids and primers used for mutant construction, verification, and complementation, see Table S3. Importantly, all of the mutants used for virulence studies were fully transduced, with the exception of the ptsH-H15A and ptsH-H15A ⌬glcU mutants. Since the ptsH-H15A mutation is markerless, we constructed and verified three independent ptsH-H15A mutants in the LAC background. We then separately transduced the ⌬glcU mutation into each of these three mutants and verified that each mutant grew identically under aerobic conditions in glucose, Casamino acids, and TSB.
Growth curves. Staphylococcus cultures were grown overnight in TSB at 37°C with shaking at 250 rpm. For aerobic, metal-restricted, and NOtreated bacterial growth curves, overnight cultures of S. aureus were washed twice with phosphate-buffered saline (PBS) and diluted into TSB with or without 2,2-dipyridyl (1 mM) or into CDM with or without carbon to an initial OD at 600 nm (OD 660 ) of 0.04. Diluted cultures were then aliquoted into a 96-well plate (200 l/well) and incubated in a Tecan Infinite M200 microplate reader set to 37°C with 1-mm orbital shaking. Growth was monitored via absorbance at 650 nm every 15 min for 24 h. For NO growth curves, 10 mM NOC-12 (Santa Cruz Biotechnology; catalog no. 202246) and 1 mM DEA NONOate (A. G. Scientific; catalog no. D-1013) were added to the cultures at an OD 650 of 0.15. To extend the fermentative phase of S. aureus NO-resistant growth, an additional, identical, dose of NO donors was added to each well 1.5 h later. To ensure continued substrate availability during such prolonged NO exposure (S. aureus utilizes carbon inefficiently during NO-induced fermentation), we used 50 mM glucose for these experiments. For anaerobic growth curves, the overnight cultures were washed twice with PBS and diluted into 5 ml of prewarmed (37°C) TSB or CDM with or without carbon with or without 50 mM potassium nitrate to an OD 660 of 0.08. Cultures were prepared in duplicate in 16-by 150-mm glass tubes containing 1-mm stir bars. Following dilution, cultures were immediately transferred into a Coy anaerobic chamber and grown at 37°C with stirring. Growth was monitored hourly by reading absorbance at 650 nm.
Growth rate and lag analysis. Growth rates were calculated with the formula ϭ ⌬ln(A 650 ) ⌬time (hours). The time intervals used for growth rate analysis are experiment specific and thus are provided in the figure legends. Lag time was calculated as the time (hours) until cultures reached an OD 650 of 0.2.
Glucose yield calculation. Glucose yield was measured in milligrams of glucose consumed per milligram (dry weight) of biomass for S. aureus COL, our primary laboratory strain. Glucose consumption was monitored by enzymatically (R-Biopharm) determining glucose in 200-l cultures of CDM plus 25 mM glucose over a 4-h period following NO exposure or during a 4-h period during aerobic or anaerobic growth at mid-exponential phase. Dry-weight biomass was determined by vacuum filtering 100 ml of mid-exponential-phase S. aureus COL culture (OD 660 of 1) in triplicate through a 10-cm Millipore 0.45-m-pore-size filter. The filter was then baked overnight at 65°C. Weights were averaged, and the weights of baked sterile filters were subtracted to yield an average dry weight of an S. aureus cell of~2.8 ϫ 10 Ϫ13 g. While S. aureus LAC (used for animal experiments) exhibits similar elevated glucose consumption under nonrespiratory conditions, the dry-weight biomass of this strain per OD unit was not directly determined, but it is not expect to differ significantly from that of COL.
All of the candidate sugar transporters from this expanded search were then compiled into a list. Next, we performed forward and reciprocal BLASTP searches for each predicted protein on this list against all Staphylococcus genomes, as well as the transporter classification database (http://www.tcdb.org). Sequence homology was determined with an E value cutoff of 1e Ϫ50 . Lastly, we used the ortholog predictor provided through xBASE (http://www.xbase.ac.uk/) and visually inspected/compared the genomic context of each gene with MetaCyc (http://metacyc.org/). Homology, as depicted in Table S1 in the supplemental material, required sequence homology (i.e., an E value of Ͻ1e Ϫ50 and a positive reciprocal BLASTP result), a corresponding result from the xBASE ortholog predictor, and a visual confirmation of shared genomic context.
Real-time qRT-PCR. S. aureus COL was grown in 50 ml of CDM plus 25 mM glucose or Casamino Acids (0.5%) in 250-ml flasks at 37°C with shaking at 250 rpm. At an OD 660 of 0.5, 25 ml of each culture was added to an equal volume of ice-cold ethanol-acetone (1:1) and frozen at Ϫ80°C (aerobic cultures). To assess gene expression during NO exposure, a separate set of cultures (CDM plus glucose) was treated with 5 mM DETA-NONOate (Cayman Chemical; catalog no. 82120) for 1 h, quenched, and then frozen. Lastly, S. aureus COL was grown in 50 ml of CDM plus glucose in the anaerobic chamber at 37°C with stirring. At an OD 660 of 0.5, 25 ml of culture was removed from the chamber in a 50-ml conical tube devoid of oxygen, immediately quenched, and then frozen. RNA was then harvested, and gene expression was analyzed as previously described (49). Transcript levels of selected genes were normalized to rpoD transcript levels, which deviated very little across our experimental conditions. For the primers used for quantitative reverse transcriptase PCR (qRT-PCR) analysis, see Table S3 in the supplemental material.
Radiolabeled-glucose uptake assays. S. aureus COL strains were grown in TSB in 50-ml culture volumes to late exponential phase (OD 660 of 1 to 1.2). Cells were centrifuged for 10 min at 5,000 ϫ g and then immediately resuspended to an OD 660 of 20 in warm CDM (37°C). At t 0 , a mixture of glucose and [ 14 C]glucose was added to a 1-ml aliquot of each culture to reach final concentrations of 2 mM glucose and 100 M [ 14 C]glucose. Cells were incubated in a 37°C heat block. At 12 min following glucose addition, 150 l of culture was removed and immediately diluted into 900 l of CDM containing 20 mM unlabeled glucose. The diluted cells were pelleted, washed once with 500 l of CDM (20 mM glucose), and then resuspended in 150 l of CDM (20 mM glucose). The resuspended cells were added to a scintillation vial containing 4 ml of EcoScint A scintillation fluid (National Diagnostics). To determine the level of radioactivity in each sample, a Beckman LS6500 Multi-Purpose Scintillation Counter was used to measure counts per minute.
Virulence assays. For virulence assessment, 6-to 8-week-old female C57BL/6 mice from The Jackson Laboratory (Bar Harbor, ME) were anesthetized with tribromoethanol (Avertin, 0.08 mg/kg; Acros Organics; catalog no. 421430100) shaved (on the flank), and injected subcutaneously (on the flank) with 1 ϫ 10 7 CFU of WT or ⌬G4, ⌬glcU, ptsH-H15A, or ptsH-H15A ⌬glcU mutant S. aureus LAC in 20 l of sterile PBS. Importantly, two separate isolates of the ptsH-H15A and ptsH-H15A ⌬glcU mutants were used for infection of at least five mice apiece. On day 5, mice were euthanized and the abscesses were removed, homogenized in 500 l of PBS, and dilution plated on TSA to enumerate CFU. To control for reversion of the ptsH-H15A mutation during infection, WT (positive control) and ptsH-H15A and ptsH-H15A ⌬glcU mutant abscesses were plated on CDM agar plus sucrose (25 mM), incubated at 37°C for 48 h, and then inspected for colonies.